We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$524M
AUM Growth
+$32.8M
Cap. Flow
-$6.68M
Cap. Flow %
-1.28%
Top 10 Hldgs %
32.2%
Holding
157
New
6
Increased
38
Reduced
96
Closed
8

Top Buys

Rank Stock Value
1
IBM icon
IBM
IBM
+$3.58M
2
ITRI icon
Itron
ITRI
+$1.9M
3
LLY icon
Eli Lilly
LLY
+$1.83M
4
LNN icon
Lindsay Corp
LNN
+$1.79M
5
EME icon
Emcor
EME
+$1.22M

Sector Composition

Rank Sector Weight
1 Healthcare 24.97%
2 Industrials 17.47%
3 Technology 16.95%
4 Energy 9%
5 Utilities 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROP icon
101
Roper Technologies
ROP
$38.8B
$1.05M 0.2%
7,559
-200
-3% -$26K
CHXX
102
DELISTED
EGSHARES CHINA INFRASTRUCTURE ETF
CHXX
$1.04M 0.2%
56,650
-4,025
-7% -$75.5K
NWE icon
103
NorthWestern Energy
NWE
$4.23B
$1.02M 0.19%
23,450
-300
-1% -$13.4K
TTEK icon
104
Tetra Tech
TTEK
$8.49B
$973K 0.19%
173,905
-9,250
-5% -$49.9K
CVGW
105
DELISTED
Calavo Growers
CVGW
$921K 0.18%
30,450
-1,800
-6% -$53.5K
TEL icon
106
TE Connectivity
TEL
$59.6B
$882K 0.17%
16,000
-900
-5% -$47.3K
ADM icon
107
Archer Daniels Midland
ADM
$38.2B
$877K 0.17%
20,200
-48,700
-71% -$1.97M
ECNS icon
108
iShares MSCI China Small-Cap ETF
ECNS
$64.9M
$864K 0.16%
18,600
-800
-4% -$36.4K
HDNG
109
DELISTED
Hardinge Inc
HDNG
$860K 0.16%
59,406
+6,400
+12% +$94.9K
NSLR
110
Neostellar Capital Corp
NSLR
$269M
$854K 0.16%
108,731
+2,002
+2% +$17.2K
HLIO icon
111
Helios Technologies
HLIO
$2.57B
$826K 0.16%
20,238
-200
-1% -$7.89K
CHMG icon
112
Chemung Financial Corp
CHMG
$393M
$825K 0.16%
24,142
SWZ
113
Swiss Helvetia Fund
SWZ
$76.5M
$775K 0.15%
55,550
-3,700
-6% -$52.6K
PEP icon
114
PepsiCo
PEP
$190B
$767K 0.15%
9,253
+1,775
+24% +$147K
PWE
115
DELISTED
Penn West Energy Petroleum Ltd
PWE
$747K 0.14%
89,305
+32,555
+57% +$312K
GXC icon
116
State Street SPDR S&P China ETF
GXC
$462M
$733K 0.14%
9,400
-600
-6% -$46K
MOS icon
117
The Mosaic Company
MOS
$7.03B
$704K 0.13%
14,900
-100
-0.7% -$4.64K
MKSI icon
118
MKS Inc
MKSI
$20.1B
$687K 0.13%
22,950
-900
-4% -$26.2K
WX
119
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
$628K 0.12%
16,350
-8,750
-35% -$276K
HAL icon
120
Halliburton
HAL
$26.9B
$619K 0.12%
12,200
-300
-2% -$15.5K
CVE icon
121
Cenovus Energy
CVE
$55.7B
$598K 0.11%
20,866
-200
-0.9% -$5.83K
BSV icon
122
Vanguard Short-Term Bond ETF
BSV
$44.7B
$594K 0.11%
7,435
+135
+2% +$10.9K
SU icon
123
Suncor Energy
SU
$79.4B
$547K 0.1%
15,612
-1,483
-9% -$52.1K
VNM icon
124
VanEck Vietnam ETF
VNM
$491M
$528K 0.1%
28,100
+2,800
+11% +$53.3K
ALLE icon
125
Allegion
ALLE
$13.4B
$488K 0.09%
+11,043
New +$478K

Similar funds

John G. Ullman & Associates's Q4 2013 Portfolio in Review

As of Q4 2013, John G. Ullman & Associates held 157 positions worth $524M, up 6.7% from $491M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

John G. Ullman & Associates's Q4 2013 filing shows 6 new, 38 increased, 96 reduced and 8 closed positions. Its largest new stake was Emcor: 31,300 shares worth $1.33M. The largest sale was Bristol-Myers Squibb, an estimated $2.98M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 25% a quarter earlier, followed by Industrials and Technology.

  • John G. Ullman & Associates's largest Q4 2013 buy was Emcor: 31,300 shares worth $1.33M.
  • John G. Ullman & Associates added most to IBM in Q4 2013, an estimated $3.58M increase.
  • John G. Ullman & Associates's biggest Q4 2013 reduction was Bristol-Myers Squibb, cutting an estimated $2.98M.
  • John G. Ullman & Associates fully exited Darling Ingredients in Q4 2013, selling an estimated $1.65M.
  • John G. Ullman & Associates's ten largest holdings make up 32% of its $524M portfolio in Q4 2013.
  • John G. Ullman & Associates opened 6 new positions and closed 8 in Q4 2013.
  • John G. Ullman & Associates's portfolio value rose 6.7% quarter-over-quarter to $524M.

Based on John G. Ullman & Associates's 13F filing for Q4 2013, filed 3 Feb 2014.